Surrozen Inc
Research Surrozen Inc (SRZN) on Bullrun: market cap USD 298.62M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSRZN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 298.62M
- Financial periodFY2025
- RevenueUSD 3.48M
- Revenue growth-67.4%
- Net income-USD 242.03M
- Free cash flow-USD 30.37M
Valuation Snapshot
latest market cap is USD 298.62M.
About Surrozen Inc
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system.
Frequently asked questions
What is Surrozen Inc's market cap?
Surrozen Inc's market capitalization is USD 298.62M.
What does Surrozen Inc do?
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair.